Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites
about
sameAs
Sulindac derivatives inhibit cell growth and induce apoptosis in primary cells from malignant peripheral nerve sheath tumors of NF1-patientsSulindac metabolites inhibit epidermal growth factor receptor activation and expression.Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cellsEffect of inhibition of extracellular signal-regulated kinase 1 and 2 pathway on apoptosis and bcl-2 expression in Helicobacter pylori-infected AGS cells.Diarrhea or colorectal cancer: can bacterial toxins serve as a treatment for colon cancer?Regulation of cytokine-induced prostanoid and nitric oxide synthesis by extracellular signal–regulated kinase 1/2 in lung epithelial cells.Effector mechanism of magnolol-induced apoptosis in human lung squamous carcinoma CH27 cells.Inhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt/β-catenin-mediated transcription in human breast tumor cells.Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model.Overcoming IGF1R/IR resistance through inhibition of MEK signaling in colorectal cancer models.NSAIDS inhibit in vitro MSC chondrogenesis but not osteogenesis: implications for mechanism of bone formation inhibition in man.SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma.Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway.Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs.Anti-angiogenic properties of a sulindac analogue.Phosphodiesterase type 5 and cancers: progress and challenges.
P2860
Q24794243-AF903077-211B-4047-8062-048280947D84Q24813782-C3CD65EB-B2CA-4E30-8DF9-4A754FE28091Q28209990-7B35213F-E061-4D57-9942-5CEA8D000F8FQ33775667-C884FA14-1935-43EB-9468-7A6FDF709166Q34581437-A7F48DA3-44A0-4A95-9537-A7D4C87D5A54Q34865462-D5CD7FA7-2ECB-4151-8FAE-8897AC6F44C0Q34881610-219AB072-5F7E-42C1-BDBE-15F89644488BQ35044880-97AC2AF4-5439-42E2-8BA9-9D6DEEE69D1FQ35151018-266CEDD9-D7AF-4898-AF6F-7549893EB690Q37119616-95285899-40DF-4FB2-A77E-03711A75CF28Q37349748-844A5675-AA2F-491B-9038-EBE242697951Q37580226-2F110B6C-952C-4E62-A847-654AE4405FC3Q40440440-C07620B5-4955-461C-9BF3-337A6081C633Q40490472-9E093F79-AADB-4C2C-BFA9-61A8A6B7737EQ40560449-1CD5A446-86CC-4686-BF60-FBDAC24CD42EQ42029292-85D41C9B-25E4-4AC9-B9C8-24B588358E56Q47171803-3DECE8B9-EFDA-4A92-8682-2A12C8F1EDD8
P2860
Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Inhibition of extracellular si ...... ptosis by sulindac metabolites
@ast
Inhibition of extracellular si ...... ptosis by sulindac metabolites
@en
Inhibition of extracellular si ...... ptosis by sulindac metabolites
@nl
type
label
Inhibition of extracellular si ...... ptosis by sulindac metabolites
@ast
Inhibition of extracellular si ...... ptosis by sulindac metabolites
@en
Inhibition of extracellular si ...... ptosis by sulindac metabolites
@nl
prefLabel
Inhibition of extracellular si ...... ptosis by sulindac metabolites
@ast
Inhibition of extracellular si ...... ptosis by sulindac metabolites
@en
Inhibition of extracellular si ...... ptosis by sulindac metabolites
@nl
P2093
P1433
P1476
Inhibition of extracellular si ...... ptosis by sulindac metabolites
@en
P2093
P304
P407
P577
2001-02-15T00:00:00Z